SCHEMBL20207439

SCHEMBL20207439

CC(=O)C1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
L3MBTL3 Q96JM7 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HRH3 Q9Y5N1 2/20 0.38
KDM4E B2RXH2 2/20 0.38
KCNH2 Q12809 1/20 0.38
LMNA P02545 1/20 0.37
ALOX15 P16050 1/20 0.37
ACHE P22303 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GSK3B P49841 2/20 0.34
DYRK1A Q13627 2/20 0.34
DPP4 P27487 1/20 0.34
USP5 P45974 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12772861 0.84 ALDH1A1 (0.50) ALDH1A1HTTL3MBTL3L3MBTL1CYP1A2
SCHEMBL13847402 0.84 ALDH1A1 (0.54) ALDH1A1HTTL3MBTL3L3MBTL1HRH3
SCHEMBL13804044 0.83 CHRM1 (0.42) ALDH1A1HTTL3MBTL3L3MBTL1HRH3
SCHEMBL19066091 0.82 CHRM1 (0.47) ALDH1A1HTTL3MBTL3L3MBTL1TDP1
SCHEMBL26157134 0.80 KDM4E (0.47) ALDH1A1HTTKDM4ELMNAALOX15
SCHEMBL81624 0.80 L3MBTL1 (0.39) ALDH1A1L3MBTL3L3MBTL1TDP1HRH3
SCHEMBL25075074 0.79 HRH3 (0.44) ALDH1A1HRH3KDM4EKCNH2ALOX15
SCHEMBL13407270 0.78 LMNA (0.47) ALDH1A1L3MBTL3L3MBTL1HRH3KDM4E
SCHEMBL12436813 0.78 LMNA (0.47) ALDH1A1L3MBTL3L3MBTL1HRH3KDM4E
SCHEMBL890089 0.78 CYP1A2 (0.44) ALDH1A1HTTCYP1A2TDP1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098296-A1 PIPERAZINE DERIVATIVES AS SELECTIVE HDAC1,2 INHIBITORS REGENACY PHARMACEUTICALS, LLC (US) 2018-05-31 WO disclosed